Free Trial
OTCMKTS:PTEO

Proteo (PTEO) Stock Price, News & Analysis

Proteo logo
$0.09 0.00 (0.00%)
As of 09/27/2022

About Proteo Stock (OTCMKTS:PTEO)

Key Stats

Today's Range
$0.09
$0.09
50-Day Range
$0.09
$0.09
52-Week Range
$20.00
$698.00
Volume
N/A
Average Volume
11 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The company focuses on the development of pharmaceuticals based on Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands for use in the treatment of post-surgery damage to tissue; complications resulting from organ transplantation; pulmonary hypertension; and injuries caused by accidents, cardiac infarction, and other diseases. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded in 1992 and is based in Irvine, California.

Receive PTEO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteo and its competitors with MarketBeat's FREE daily newsletter.

PTEO Stock News Headlines

A grave, grave error.
President Donald Trump made headlines last month with a staggering claim. He stated that since taking office, more than $12 trillion in private investments into America have been “practically committed” on his watch. "Nobody's ever seen numbers like we have," he said, crediting his agenda of tariffs, tax cuts, and deregulation with making the difference. If true, the figure would indeed be astonishing – potentially tripling the roughly $4 trillion in gross private investment the US reported all of last year.
LTHO Legacy Technology Holdings, Inc.
ITONF Ito En, Ltd. Class A Preferred Shares
See More Headlines

PTEO Stock Analysis - Frequently Asked Questions

Proteo's stock was trading at $0.0899 on January 1st, 2025. Since then, PTEO stock has increased by 0.0% and is now trading at $0.0899.
View the best growth stocks for 2025 here
.

Shares of PTEO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Proteo investors own include ASAP (WTRH), Trigon Metals (TM), SoundThinking (SSTI), PagSeguro Digital (PAGS), Kaya (KAYS) and Energizer (ENR).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:PTEO
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (OTCMKTS:PTEO) was last updated on 6/22/2025 by MarketBeat.com Staff
From Our Partners